TFQO: Jasmeet Soar #COI 272 EVREV 1: Jasmeet Soar #COI 272 EVREV 2: Michael Donnino #COI 222 Taskforce: ALS ALS 448 OXYGEN DOSE AFTER ROSC IN ADULTS 3.

Slides:



Advertisements
Similar presentations
Ventilation techniques used by lifeguards Bo Løfgren, MD, PhD Honorary Associate Professor in Resuscitation and Emergency Medicine Department of Internal.
Advertisements

Dallas 2015 TFQO: Tony Scott #138 EVREV 1: Tony Scott #138 EVREV 2: Anthony Seto # Taskforce: ACS Supplemental Oxygen in ACS 887.
Dallas 2015 TFQO: Allan de Caen COI#38 EVREV 1: Melissa Parker COI#259 EVREV 1: Takanari Ikeyama COI#235 Taskforce: Pediatrics Peds 820 : The use of fluids.
Dallas 2015 TFQO: Myra Wyckoff #COI EVREV 1: Myra Wyckoff #COI EVREV 2: Lindsay Mildenhall #107 Taskforce: NRP NRP: 605 Two thumb verses two finger.
Dallas 2015 TFQO: Marya Strand, MD, MS; COI#222 EVREV 1: Marya Strand, MD, MS; COI#222 EVREV 1: Takahiro Sugiura, MD; COI#224 Taskforce: NLS Umbilical.
Dallas : CPAP and IPPV In spontaneously breathing preterm infants with respiratory distress requiring respiratory support in the delivery room,
Chicago 2014 TFQO: Kee-Chong Ng (#COI = 113) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: EVREVs: de Almeida, Maria Fernanda COI# Trevisanuto, Daniele COI# Taskforce: Neonatal Warming Adjunts #599 Among preterm neonates who.
Chicago 2014 Peter Morley, Eddy Lang E3, GRADE expert Incorporating lower levels of evidence.
Dallas 2015 TFQO: David Stanton COI 328 EVREVs: Volker Wenzel COI 253& Emmanuelle Bourdon COI 333 Taskforce: BLS Passive ventilation techniques.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI 261 EVREV 2: Daniel Pichel COI # 513 Taskforce: ACS ACS 335: Pre-hospital ADP- Receptor.
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Charles Deakin COI #221 Taskforce: ALS ALS 714 : Advanced airway placement (SGA.
Peds-818: Pediatric Early Warning Scores
Dallas 2015 TFQO: Vinay Nadkarni MD COI#249 EVREV 1: Graeme Maclaren MBBS COI#98 EVREV 2: Ravi Thiagarajan MBBS, MPH COI#149 Taskforce: PALS Peds 819 :
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI #261 EVREV 2: Daniel Pichel COI #513 Taskforce: ACS ACS 873: Pre-hospital STEMI Activation.
Dallas 2015 TFQO: Jeffry Pearlman COI# 187 EVREV 1: Enrique Udaeta COI# 239 EVREV 1: Edgardo Ezslyd COI# 277 Taskforce: NRP Laryngeal Mask Airway (NRP.
Dallas 2015 TFQO: EVREVs: Aaron Donoghue / Jonathan Duff Taskforce: EIT Teaching Compression-Only CPR.
Dallas 2015 TFQO: Masanori Tamura #147 EVREV 1: Masanori Tamura #147 EVREV 2: Susan Niermeyer #252 Delayed Cord Clamping in Preterm Infants Including those.
Therapeutic Hypothermia in Out of Hospital Cardiac Arrest towards
NRP: 862: Use of Feedback CPR Devices for Neonatal Cardiac Arrest NRP: 863: Use of Feedback CPR Devices to detect ROSC for Neonatal Cardiac Arrest TFQO:
Chicago 2014 TFQO: Peter Meaney #COI 149 EVREV 1: Richard Aickin #COI 153 EVREV 1: Peter Meaney #COI 149 Taskforce: Pediatrics Resuscitation fluids (Peds)
Dallas 2015 TFQO: Marilyn Escobedo COI#78 EVREV 1: Marilyn Escobedo COI#78 EVREV 2: Henry Lee COI#135 Taskforce: NRP Babies born to mothers who are hypothermic.
Dallas 2015 TFQO: Robert Greif EVREVs: Jan Breckwoldt, Henrik Fischer Taskforce: Education Implementation and Training (EIT) AED training methods.
Dallas 2015 TFQO: Enrique Udaeta COI# 239 EVREV 1: Enrique Udaeta COI# 239 EVREV 1: Edgardo Ezslyd COI# 277 Taskforce: NRP Laryngeal Mask Airway (NRP 618)
Dallas 2015 TFQO: EVREVs: Guinsburg, Ruth COI# McGowan, Jane COI# Taskforce: Neonatal Apgar Zero #896 In infants ≥36 weeks GA with an Apgar score.
Dallas 2015 TFQO: Name EVREV 1: Jonathan Wyllie COI #282 EVREV 1: Jeff Perlman COI #262 Taskforce: Newborn Temperature Maintenance in the Delivery room.
Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.
Chicago 2014 TFQO: Darren Walters COI #317 EVREV 1: Darren Walters COI #317 EVREV 2: Chris Ghaemmaghami COI #60 Taskforce: Acute Coronary Syndrome In STEMI.
Dallas 2015 TFQO: Anne-Marie Guerguerian # 97 EVREV1: Anne-Marie Guerguerian # 97 EVEREV2: Ericka Fink # 83 Taskforce: PEDS Peds 407 : ECMO for pediatric.
Dallas 2015 TFQO: Darren Walters EVREVs: EVREV 1: Darren Walters COI #422 EVREV 2: Chris Ghaemmaghami COI #89 Taskforce: Acute Coronary Syndrome Fibrinolytic.
ITU Journal Club: Dr. Clinton Jones. ST4 Anaesthetics.
First Aid 801: Stroke Recognition
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 4 (maximum) using standard.
Dallas 2015 TFQO: David Boyle COI #26 EVREV 1: David Boyle #COI#26 EVREV 1: Jane McGowan #370 Taskforce: Neonatal Ventilation Strategies in the DR (NRP.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 6 (maximum) using standard.
Dallas 2015 TFQO: Michael Sayre COI #400 EVREV 1: Mohamud Daya COI #327 EVREV 2: Jan-Thorsten Gräsner COI #230 Taskforce: BLS BLS 363: CPR Prior to Defibrillation.
Chicago 2014 TFQO: Charles Deakin #329 EVREV 1: Asger Granfeldt COI #63 EVREV 2: Bo Lofgren COI #363 Taskforce: ALS ALS 571 : Ventilation strategy post-ROSC.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
UT Southwestern Medical Center at Dallas
Dallas 2015 TFQO: Kee-Chong Ng (#COI = 170) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
Chicago 2014 Pediatric RRT/MET Teams #397 TFQO: Dianne Atkins COI #7 EVREV 1: Dianne Atkins EVREV 2: Kee Chong Ng COI #113 Taskforce: Peds.
Dallas 2015 TFQO: Maaret Castrén #320 EVREV 1: Christian Vaillancourt #416 EVREV 2: Michael Sayre #400 Taskforce: BLS BLS 359: Dispatcher Instructions.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREVs: Jan Jensen COI #115 Richard N. Bradley COI #151 Taskforce: First Aid 769: Hemostatic Dressings.
Dallas 2015 TFQO: Monica Kleinman COI #353 EVREV 1: Janice Tijssen COI#232 EVREV 2: Javier Urbano COI#240 Taskforce: Peds Peds 815: Pediatric goal-directed.
Dallas 2015 TFQO: Judith Finn EVREVs: Judith Finn #227 / Dion Stub #COI Taskforce: EIT Cardiac Arrest Centres.
Dallas 2015 TFQO: Michael W. Donnino COI# EVREVs: Katherine M. Berg COI# Lars W. Andersen COI# Taskforce: ALS Ultrasound During CPR.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREV: Michael Reilly COI #193 Taskforce: First Aid First Aid 768: Use of Tourniquet.
Dallas 2015 TFQO: Koen Monsieurs 372 EVREV 1: Koen Monsieurs 372 EVREV 2: Ahamed Idris 349 Taskforce: BLS BLS366 Chest Compression Depth (adults)
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Jan-Thorsten Graesner COI #150 Taskforce: ALS ALS 783 : Advanced versus basic.
Dallas 2015 TFQO: Robert Greif EVREVs: Dana Edelson, COI #334 Robert Greif, COI #344 Taskforce: EIT EIT 645: Debriefing of resuscitation performance.
Dallas 2015 TFQO: Hiroshi Nonogi #254 EVREVs: Hiroshi Nonogi #254 Tony Scott #138 Taskforce: ACS Fibrinolytic and immediate PCI for STEMI 882.
LINC Trial LUCAS in cardiac arrest trial. What is LINC? A multicenter, randomized, controlled trial designed to evaluate the efficacy and safety of: LUCAS.
Induced Hypothermia After VF Cardiac Arrest Improves Outcomes Summary and Comment by Kristi L. Koenig, MD, FACEP Published in Journal Watch Emergency Medicine.
Dallas 2015 TFQO: S. Velaphi EVREV 1: N. Singhal COI #213 EVREV 2: S. Velaphi COI #242 EVREV 3: H. Ersdal – COI # 76 Taskforce: NLS Prognosis: In newborn.
Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.
Dallas 2015 TFQO: Name EVREVs: Names and #COI Taskforce: Name Insert Short PICO title Total of 12 (no studies) to 20 slides (maximum) using standard format.
Dallas 2015 TFQO: Jonathan Witt (COI #418) EVREVs: Steve Lin (COI #137), Thomas Pellis (COI #186) and Katie Dainty (COI #) Taskforce: ALS ALS 428 : Antiarrhythmic.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
Abstract Cardiopulmonary Resuscitation with Rescue Breathing Is Superior to Hands-Only Cardiopulmonary Resuscitation for Children and Infants: Results.
Dallas 2015 TFQO: Jasmeet Soar #COI 409 EVREV 1: Jasmeet Soar #COI 409 EVREV 2: Anthony Lagina #COI 357 Taskforce: ALS ALS 889 OXYGEN DOSE DURING CPR IN.
Dallas 2015 TFQO: Michael Donnino #222 EVREV 1: Joshua Reynolds COI #265 EVREV 2: Katherine Berg COI #10 Taskforce: ALS ALS 790 : Induced Hypothermia.
ED and Hospital Care Can Improve Survival after Cardiac Arrest
SSAI Malmö MD, PhD, FCICM, EDIC Markus Skrifvars
Extracorporeal Cardiopulmonary Resuscitation (ECPR) in Adults:
ALPS Trial design: Patients with adult nontraumatic out-of-hospital cardiac arrest (OOHCA) and persistent or recurrent VT/VF after ≥1 shock were randomized.
What is LINC? A multicenter, randomized, controlled trial
Arterial blood gas measurement of oxygen tension.
Presentation transcript:

TFQO: Jasmeet Soar #COI 272 EVREV 1: Jasmeet Soar #COI 272 EVREV 2: Michael Donnino #COI 222 Taskforce: ALS ALS 448 OXYGEN DOSE AFTER ROSC IN ADULTS 3 January 2015

COI Disclosure Jasmeet Soar #COI 272 Commercial/industry None Potential intellectual conflicts None Michael Donnino COI#222 Commercial/industry None Potential intellectual conflicts None

2010 Treatment Recommendation There is insufficient clinical evidence to support or refute the use of inspired oxygen concentration titrated to arterial blood oxygen saturation in the early care of cardiac arrest patients following sustained ROSC.

C2015 PICO P - Among adults who have ROSC after cardiac arrest in any setting I - Does an inspired oxygen concentration titrated to oxygenation (normal oxygen saturation or partial pressure) C - Compared with the use of 100% inspired oxygen O – Improve Survival with favorable neurological/functional outcome at discharge, 30 days, 60 days, 180 days AND/OR 1 year (9 - critical outcome), Survival at discharge, 30 days, 60 days, 180 days AND/OR 1 year (8 - critical outcome)? ICU survival (5 - important)?

Inclusion/Exclusion Inc lude Human adult studies Observational, non-RCT studies Exclude Paediatric studies Animal studies Reviews, editrorials

Pubmed/Embase/Cochrane Search 26 November articles reviewed in detail + 2 further articles identified 2359 citations 8 articles in final review 1 RCT 7 non-RCTs 2347 excluded Title review/abstract review Not relevant 6 excluded (4 paediatric, 1 oxygen during CPR, 1 no PaO2 data) Search details As of 5 December further non-RCT identified by authors Vaahersalo et al. Crit Care Med 2014; 42:1463–1470) Elmer et al. Intensive care Medicine. Dec studies in updated review 1 RCT, 9 non-RCT

2015 Proposed Treatment Recommendations We recommend the avoidance of hypoxia in adults with ROSC after cardiac arrest in any setting (strong recommendation, very low quality evidence). We suggest the avoidance of hyperoxia in adults with ROSC after cardiac arrest in any setting (weak recommendation, very low quality evidence). We suggest the use of 100% inspired oxygen until the arterial oxygen saturation or the partial pressure of arterial oxygen can be measured reliably in adults with ROSC after cardiac arrest in any setting (weak recommendation, very low quality evidence).

Risk of Bias in RCTs

Risk of Bias in non-RCTs

Proposed Consensus on Science statements 30% inspired oxygen for 60 minutes after ROSC vs. 100% inspired oxygen for 60 minutes after ROSC For the critical outcome of survival to hospital discharge with favourable neurological outcome (CPC 1 or 2) we identified very low quality evidence from one RCT [Kuisma ] that showed no difference between 30% inspired oxygen for 60 minutes after ROSC vs.100% inspired oxygen for 60 minutes after ROSC. For the critical outcome of survival to hospital discharge we identified very low quality evidence from one RCT [Kuisma ] that showed no difference between 30% inspired oxygen for 60 minutes after ROSC and 100% inspired oxygen for 60 minutes of after ROSC

Consensus on Science statements Hyperoxia vs. Normoxia (1) For the critical outcome of survival with favourable neurological outcome (CPC 1 or 2) at 12 months we identified very low quality evidence from 1 study [Vaahersalo ] that showed no harmful effect from hyperoxia during the first 24 hours of ICU care. For the critical outcome of survival to hospital discharge with favourable neurological outcome (CPC 1 or 2) we have identified very low quality evidence from 5 observational studies [Janz , Roberts , Elmer 2014, Kilgannon , Bellomo 2011 R90] with conflicting results [2 showed hyperoxia worse than normoxia].

Consensus on Science statements Hyperoxia vs. Normoxia (2) For the critical outcome of survival to discharge (or survival to 30 days) we have identified very low quality evidence from 7 observational studies [Kilgannon , Kilgannon , Bellomo 2011 R90, Janz , Ihle , Nelskyla 2013, Elmer 2014] with conflicting results [4 showed hyperoxia worse than normoxia]. For the important outcome of survival to ICU discharge we have identified very low quality evidence from 2 observational studies [Ihle , Nelskyla 2013] that showed no harm from hyperoxia.

Consensus on Science statements Hypoxia vs. Normoxia () For the critical outcome of survival to discharge (or survival to 30 days) we have identified very low quality evidence from 3 observational studies [Kilgannon , Bellomo 2011 R90, Ihle ] - 2 showed harm from hypoxia For the important outcome of survival to ICU discharge we have identified very low quality evidence from 1 observational studies [Ihle ] that showed harm from hypoxia.

Draft 2015 Treatment Recommendations We recommend the avoidance of hypoxia in adults with ROSC after cardiac arrest in any setting (strong recommendation, very low quality evidence). We suggest the avoidance of hyperoxia in adults with ROSC after cardiac arrest in any setting (weak recommendation, very low quality evidence). We suggest the use of 100% inspired oxygen until the arterial oxygen saturation or the partial pressure of arterial oxygen can be measured reliably in adults with ROSC after cardiac arrest in any setting (weak recommendation, very low quality evidence).

Knowledge Gaps Is it feasible to assess arterial oxygenation after ROSC? Can inspired oxygen be titrated immediately after ROSC? What is the optimum arterial oxygenation Immediately after ROSC? In first 24, 48 or 72 h after ROSC? How is arterial oxygenation assessed in studies SaO2 vs. PaO2? Serial readings of SaO2? Highest lowest readings?